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Abstract: Regulation of lipid metabolism is essential for treatment and prevention of several chronic
diseases such as obesity, diabetes, and cardiovascular diseases, which are responsible for most
deaths worldwide. It has been demonstrated that the AMP-activated protein kinase (AMPK) has
a direct impact on lipid metabolism by modulating several downstream-signaling components.
The main objective of the present work was to evaluate the in vitro effect of a methanolic strawberry
extract on AMPK and its possible repercussion on lipid metabolism in human hepatocellular
carcinoma cells (HepG2). For such purpose, the lipid profile and the expression of proteins
metabolically related to AMPK were determined on cells lysates. The results demonstrated that
strawberry methanolic extract decreased total cholesterol, low-density lipoprotein (LDL)-cholesterol,
and triglycerides levels (up to 0.50-, 0.30-, and 0.40-fold, respectively) while it stimulated the
p-AMPK/AMPK expression (up to 3.06-fold), compared to the control. AMPK stimulation led
to the phosphorylation and consequent inactivation of acetyl coenzyme A carboxylase (ACC) and
inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the major regulators of fatty
acids and cholesterol synthesis, respectively. Strawberry treatment also entailed a 4.34-, 2.37-, and
2.47-fold overexpression of LDL receptor, sirtuin 1 (Sirt1), and the peroxisome proliferator activated
receptor gamma coactivator 1-alpha (PGC-1α), respectively, compared to control. The observed
results were counteracted by treatment with compound C, an AMPK pharmacological inhibitor,
confirming that multiple effects of strawberries on lipid metabolism are mediated by the activation of
this protein.
Keywords: strawberry; cholesterol synthesis; fatty acids synthesis; hypolipidemic agent
1. Introduction
Dyslipidemia—a major disorder of lipoprotein metabolism—is one of the main risk factors
for cardiovascular diseases (CVDs) including coronary heart disease, heart attacks, strokes, and
peripheral vascular disease [1–3], which are responsible for most deaths worldwide [4,5]. Elevated total
cholesterol, low-density lipoprotein (LDL)-cholesterol, and triglycerides levels are also correlated with
type 2 diabetes, insulin resistance [1], and chronic renal disease [6]. Hence, understanding lipid
metabolism is essential for the treatment and prevention of all these pathologies.
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Recently, the AMP-activated protein kinase (AMPK) has been proposed as a potential therapeutic
target for the treatment of several chronic diseases including obesity, type 2 diabetes, and CVDs [7,8].
AMPK is a serine/threonine protein kinase that plays a central role in regulating cellular metabolism
and energy balance in mammalian cells [9]. When cellular energy stores are depleted by stimuli
such as muscle contraction, hypoxia, or myocardial ischaemia, AMPK is activated. Once activated,
AMPK induces ATP generation pathways such as glycolysis, fatty acid oxidation, and lipolysis. On the
contrary, anabolic pathways like gluconeogenesis, and cholesterol and protein synthesis are inhibited.
The overall effects of this protein—when activated—on the lipid metabolism are to stimulate fatty acid
oxidation and to block cholesterol and triglycerides synthesis [9,10].
Of current interest are the effects of naturally occurring compounds in the treatment and/or
prevention of particular diseases by activating AMPK. Many of these natural compounds, including
epigallocatechin gallate, resveratrol, quercetin, theaflavin, curcumin, berberine, ginsenoside, and
caffeic acid phenethyl ester, belong to the polyphenols family [10]. Therefore, it is suggested that
polyphenolic compounds from natural sources may be used to activate AMPK.
In this context, strawberries (Fragaria × ananassa) are one of the richest dietary sources of
phytochemicals, mainly represented by flavonoids, hydrolysable tannins, and phenolic acids [11,12].
Scientific evidence indicates the role of this berry in the diminution of oxidative damage and
inflammation, which play a critical role in the development of chronic diseases [13]. In different
models of obesity/diabetes, it has been demonstrated that whole strawberries or purified anthocyanin
supplementation normalize blood glucose levels and limit glucose transport and uptake [14].
In addition, data from in vitro experiments suggest that the bioactive compounds from strawberries
can modify the cell membrane composition, functionality, and fluidity, protecting lipid bilayers against
oxidative damage [15,16].
In obese and lean C57BL/6 mice models, strawberry supplementation decreases plasma c-reactive
protein (CRP) and overall blood glucose concentrations independently of the dietary fat content,
demonstrating a protective effect against cardiovascular risk [17]. In addition, some clinical studies
observed that strawberry intake ameliorates some atherosclerotic risk factors by reducing circulating
levels of vascular cell adhesion molecule 1 [13], and CRP [18,19], decreasing lipid peroxidation [19],
and improving lipid profile [13,19,20].
The reduction of lipid levels in plasma can be explained through the ability of strawberry
polyphenols to activate the molecular signaling pathways involved in lipid metabolism, but this
hypothesis must still be confirmed. The main objective of the present work was to evaluate the in vitro
effect of strawberry (cv. Romina) methanolic extract on AMP-activated protein kinase (AMPK) cascade
and its possible repercussion on lipid metabolism in human hepatocellular carcinoma cells (HepG2).
2. Materials and Methods
2.1. Preparation of Strawberry Extract
Strawberry fruits, Fragaria × ananassa (cv. Romina) were collected in the experimental fields
of Azienda Agraria Didattico Sperimentale (Università Politecnica delle Marche, Ancona, Italy).
Within 2 h after harvest, whole fruits were stored at −80 ◦C until time of analyses. For the strawberry
extract preparation, 10 g of fruits were added to 100 mL of the extraction solution, consisting
of methanol/MilliQ water/concentrated formic acid (80:20:0.1 v/v), and homogenized using an
Ultraturrax T25 homogenizer (Janke & Kunkel, IKA Labortechnik). Extraction was maximized by
stirring the suspension for 2 h in the dark at room temperature. The mixture was then centrifuged at
2400× g for 15 min in two sequential times, to sediment solids. Supernatants were filtered through
a 0.45 µm Minisart filter (PBI International), transferred to 5.0 mL amber glass vials, and stored at
−80 ◦C until analysis. For cellular treatment, the methanolic extract was further concentrated and
dried through a rotary evaporator and stored in aliquots at −80 ◦C.
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2.2. Strawberry Extract Characterization
2.2.1. Total Phenolic Compounds (TPC) and Flavonoids Content Determination
TPC of the strawberry extract was determined using the Folin-Ciocalteu method, as modified by
Slinkard and Singleton [21], while the total flavonoid content was determined through a colorimetric
method previously described by Jia et al. [22] and Dewanto et al. [23].
2.2.2. Vitamin C Content Determination
For vitamin C quantification, the extracting solution consisted of MilliQ water containing 5%
meta-phosphoric acid and 1 mM ethylenediaminetetraacetic acid. Vitamin C was extracted by
sonication of 1 g of frozen strawberries in 4 mL of extracting solution, for the duration of 5 min, after a
previous homogenization using an Ultraturrax T25 homogenizer (Janke & Kunkel, IKA Labortechnik,
Staufen im Breisgau, Germany) at medium-high speed for 2 min. After the ultrasound assisted
extraction, solids were precipitated by centrifugation at 1720× g for 10 min at 4 ◦C, and the supernatant
was filtered through a 0.45 µm filter into 1.8 mL high-performance liquid chromatography (HPLC) vials
and immediately analyzed as described by Helsper et al. [24] in an HPLC system (Jasco, PU-2089 plus).
2.2.3. Identification and Quantification of Strawberries Anthocyanins
Analysis of anthocyanins was carried out following the method described by Terefe et al. [25].
Anthocyanins were separated from the methanolic extract on an Aqua Luna C18 (2) (250 × 4.6 mm)
reverse phase column with a particle size of 5 µm (Phenomenex) protected by a Phenomenex
4.0 × 3.0 mm C18 ODS guard column. The samples were diluted appropriately and filtered
using a 0.45 µm filter prior to injection into the HPLC system (Jasco, PU-2089 plus).
Anthocyanins were quantified using external Cyanidin-3-O-glucoside, Pelargonidin-3-O-glucoside,
and Pelargonidin-3-O-rutinoside calibration curves.
2.2.4. Total Antioxidant Capacity (TAC) Determination
For TAC determination, three different methods were employed: the Ferric Reducing Antioxidant
Power (FRAP) method described by Deighton et al. [26]; the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free
radical method described by Kumaran and Karunakaran [27]; and the Trolox Equivalent Antioxidant
Capacity (TEAC) method described by Re et al. [28].
2.3. Cells Culture and Cells’ Lysates Preparation
HepG2 cells were kindly provided by the Biological Research Laboratory of Seville University
(Spain), and were grown in Dulbecco’s modified Eagle’s medium (DMEM), supplemented with 10%
fetal bovine serum (FBS), 100 IU/mL penicillin, and 100 µg/mL streptomycin at 37 ◦C with 5% CO2.
After treatments with the strawberry dried methanolic extract, compound C, or lovastatin for the
indicated times (as detailed below), cells were lysed in a buffer containing 20 mM Tris–HCl (pH 7.5),
0.9% NaCl, 0.2% Triton X-100, and 1% of the protease inhibitor cocktail (Sigma-Aldrich, Milan, Italy)
and then stored at −80 ◦C for further western blot analysis or were lysed in radioimmunoprecipitation
assay (RIPA) buffer (Sigma-Aldrich, Milan, Italy) for lipid profile determination. All the analyses were
conducted on cells between the third and the sixth passage.
2.4. Cytotoxicity Assay
Cells were seeded at a density of 5 × 103 cells/well into 96-well plates and treated with different
concentrations of the dried methanolic extract (from 0 to 1 mg/mL) for 24, 48, and 72 h. Therefore, 30 µL
of RPMI medium containing 2 mg/mL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) were added and cells were incubated for other 2 h. MTT solution was then discarded and 100 µL
of dimethyl sulfoxide were added to dissolve the formazan crystals. The level of colored formazan
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derivative was analyzed on a microplate reader (Thermo Scientific Multiskan EX, Monza, Italy) at a
wavelength of 590 nm [29,30]. The viable cells were directly proportional to the formazan production.
2.5. Western Blotting Analysis
Equal amounts of protein (75 µg) of each sample were loaded and separated in a 10%
acrylamide sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS/PAGE) and transferred to
nitrocellulose membranes (Bio-Rad) by using a Trans-Blot Turbo Transfer System (Bio-Rad Laboratories,
Inc., Hercules, CA, USA). Membranes were washed three times with PBS, blocked with 5% non-fat
dry blocker (Bio-Rad), and incubated with the primary antibody at 4 ◦C overnight. All the polyclonal
antibodies for the protein of interest were purchased from Santa Cruz Biotechnology, Inc., Dallas, TX,
USA. Next, membranes were washed with 5% Tween 20 in Tris HCl buffered saline and incubated
with the secondary anti-rabbit immunoglobulin G-Peroxidase antibody (Sigma-Aldrich, Milan, Italy).
Protein bands were visualized using Immobilon Western Chemiluminescent Substrate (Millipore
Corporation, Billerica, MA, USA), and the protein signals were detected by a Lycor C-Digit Blot Scanner.
Quantification of protein expression was made using the software (Image Studio 3.1) provided by the
manufacturer of the Blot Scanner (LI-COR Biotechnology, Bad Homburg, Germany).
2.6. Mitochondrial Functionality
Oxygen consumption rate (OCR) was measured in real-time using an XF24 Extracellular
Flux Analyzer (Seahorse Bioscience, Billerica, MA, USA) according to the manufacturer’s protocol.
Cells were seeded at a density of 3 × 104 cells/well in 24-well plates and treated with the strawberry
dried methanolic extract for 24 h. Before the running started, the medium was replaced with DMEM
(containing 25 mM glucose, 2 mM glutamine, 1 mM sodium pyruvate, and without serum, pH 7.4) and
plates were pre-incubated in the absence of CO2 in a XF Prep Station (Seahorse Bioscience, Billerica,
MA, USA) at 37 ◦C. After finishing calibration, the plate containing cells was placed into the XF24
Extracellular Flux Analyzer (Seahorse Bioscience, Billerica, MA, USA) and mitochondrial functionality
was evaluated by sequential injection of four compounds that affect bioenergetics, as follows: 55 µL of
oligomycin into port A (final concentration 2.5 µg/mL); 61 µL of carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP) into port B (final concentration 2.5 µM); and 68 µL of rotenone/antimycin A
into port C (final concentration 1 µM/10 µM). The best concentration of each inhibitor and uncoupler,
as well as the optimal cells seeding density were determined in preliminary analyses. A minimum of
five wells per treatment were utilized in any given experiment.
2.7. Determination of Total Cholesterol, LDL-Cholesterol, and Triglycerides Levels
Total cholesterol, LDL-cholesterol, and triglycerides levels were determined by enzymatic
colorimetric kits (Spinreact, St. Esteve d’en Bas, Girona, Spain) with the employment of a microplate
reader (Thermo Scientific Microplate Reader, Multiskan®, Monza, Italy) coupled to an Ascent software
program (Thermo LabSystems Oy, Version 2.6, Navi Mumbai, India).
2.8. Determination of Total Lipid Accumulation by Oil Red O Staining
Total lipid accumulation was evaluated according to the method previously described by
Liu et al. [31]. Cells were seeded at a density of 1.5 × 105 cells/well in 6-well plates and treated
for 24 h with the strawberry dried methanolic extract, compound C, or lovastatin. Subsequently, cells
were rinsed twice with PBS and fixed in 4% paraformaldehyde in PBS for 30 min. Then, cells were
stained with Oil Red O working solution for 1 h at room temperature and subsequently rinsed with
water. The Oil Red O stock solution was prepared by dissolving 0.35 g of Oil Red O (Sigma Aldrich,
Milan, Italy) in 100 mL of isopropanol by gentle heating and then cooled and filtered through a
0.45 µm filter. The working solution was prepared by diluting three parts of the stock solution in
two parts of MilliQ water (stock solution:MilliQ water; 3:2 v/v). The cell images were captured
with a Leitz Fluovert FU (Leica Microsystems, Wetzlar, Germany) microscope. Lipids appeared red.
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For quantitative analysis of cellular lipids, 1 mL isopropanol was added to each well of the stained
culture plate. The extracted dye was immediately removed by gentle pipetting and its absorbance was
measured at 510 nm.
2.9. Statistical Analysis
Statistical analyses were performed using STATISTICA software (Statsoft Inc., Tulsa, OK, USA).
Data were subjected to one-way analysis of variance for mean comparison, and significant differences
among different treatments were calculated according to Tukey’s HSD (honest significant difference)
multiple range test. Data are reported as mean ± standard deviation (SD). Differences at p < 0.05 were
considered statistically significant. All the analyses were performed in triplicate.
3. Results
3.1. Characterization of Romina Strawberry Extract
The phytochemical composition of the strawberry extract demonstrated that the Romina
strawberry cultivar is a significant source of polyphenols (2.64 ± 2.63 mg gallic acid equivalent
(GAeq)/g fresh weight (FW)), in particular of flavonoids (1.02 ± 0.87 mg catechin equivalent (CATeq)/g
FW) (Table 1). TPC was similar to the values reported by Capocasa et al. [32] and Tulipani et al. [16]
for other commercial varieties like Sveva (2.7 mg GAeq/g FW) and Camarosa (2.6 mg GAeq/g FW)
and even higher than the values reported for Adria and Alba (1.8 and 2 mg GAeq/g FW, respectively).
Table 1. Phytochemical composition and antioxidant capacity of strawberry fruit and methanolic
extract.
Parameters Fresh Fruit Dried Methanolic Extract
Total Polyphenols (mg GAeq/g) 2.64 ± 2.63 23.44 ± 0.22
Total Flavonoids (mg CATeq/g) 1.02 ± 0.87 5.21 ± 0.29
Vitamin C (mg/g) 0.39 ± 0.23 9.09 ± 4.45
Cyanidin-3-O-glucoside (mg/g) 0.03 ± 0.02 0.69 ± 0.41
Pelargonidin-3-O-glucoside (mg/g) 0.70 ± 0.25 16.32 ± 5.71
Pelargonidin-3-O-rutinoside (mg/g) 0.04 ± 0.08 0.93 ± 1.39
TAC (µmol Txeq/g)
FRAP 22.70 ± 2.03 168.25 ± 3.95
DPPH 8.11 ± 0.25 30.29 ± 0.18
TEAC 10.71 ± 0.58 35.51 ± 0.06
mg GAeq/g: mg of gallic acid equivalent/g of fresh fruit or dried strawberry methanolic extract; mg CATeq/g:
mg of catechin equivalent/g of fresh fruit or dried strawberry methanolic extract; µmol Txeq/g: µmol of Trolox
equivalent/g of fresh fruit or dried strawberry methanolic extract; TAC: total antioxidant capacity; FRAP: Ferric
Reducing Antioxidant Power; DPPH: 2,2-diphenyl-1-picrylhydrazyl; TEAC: Trolox Equivalent Antioxidant Capacity.
Also, the total flavonoids content (TFC) was higher than the values reported for Adria (0.4 mg
CATeq/g FW) and Sveva (0.6 mg CATeq/g FW) [16] while the vitamin C content (0.39 ± 0.23 mg/g
FW) was within the values reported by Tulipani et al. [33], who indicated that the average vitamin C
content in five selected cultivars (Alba, Irma, Patty, Adria, and Sveva) and three advanced selections
(AN94.414.52, AN03.338.51, AN00.239.55) of strawberries ranged from 0.23 to 0.47 mg/g FW.
Regarding the anthocyanins reported in Table 1, they were identified through their spectral and
chromatographic characteristics and were in correspondence with the main anthocyanins reported for
strawberries. The individual quantified value of Pelargonidin-3-O-glucoside (the most representative
compound of this group) was significantly higher (0.70 ± 0.25 mg/g FW) than the values reported
for Sveva, Alba, and Adria [16,33], although lower than the value reported for this cultivar by
Diamanti et al. [34]. These results confirmed that the quality of this cultivar is quite good.
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Once the strawberry methanolic extract was concentrated and dried, its TPC, TFC, and
Pelargonidin-3-O-glucoside concentration were 23.44 ± 0.22 mg GAeq/g dried weight (DW),
5.21 ± 0.29 mg CATeq/g DW, and 16.32 ± 5.71 mg/g DW, respectively. In general, the presence
of phenolic compounds and vitamin C is often correlated to the antioxidant power of fruits, since these
compounds are efficient oxygen radical scavengers. TAC of Romina fruits was determined by three
different methods (Table 1). Results confirmed that the Romina strawberry variety not only presents a
good nutritional quality but also a high antioxidant capacity.
3.2. Effects of Strawberry Extract on HepG2 Cell Viability
Viability of HepG2 cells treated with different concentrations of strawberry dried methanolic
extract was first determined using the MTT assay. The results showed that after 24 h of treatment the
strawberry dried methanolic extract at concentrations up to 100 µg/mL did not significantly (p < 0.05)
cause cell death with respect to control (Figure 1).
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Figure 1. Viability of human hepatocellular carcinoma cells (HepG2) cells after treatment with
strawberry dried methanolic extract. Cells were incubated with the indicated concentrations for
24, 48, and 72 h. IC50 indicates the concentration of strawberry dried methanolic extract which reduces
the cells viability about 50%. Values are expressed as mean ± SD of three independent experiments
(n = 3). Asterisk marks indicate the concentrations from which significant differences (p < 0.05) were
observed compared to the control.
Significant cytotoxicity (p < 0.05) was observed at higher concentrations or longer treatment
times, although in all cases the IC50 was higher than 2.5 mg/mL. Hence, the concentrations 10, 50,
and 10 µg/ L of dried ethanolic extract were used in subsequent experiments.
3.3. Effects of Strawberry Extract on AMPK Activation
To investigate whether strawberry extract regulates metabolism in HepG2 cells via AMPK
pathway, the protein levels of phosphorylated AMPK (p-AMPK), total AMPK, sirtuin1 (Sirt1), and
liver kinase B1 (LKB1) were examined. As demonstrated in Figure 2, treatment with strawberry dried
methanolic extract significantly (p < 0.05) increased the expression of all these proteins in a dose
dependent manner.
Twenty-four hours of treatment with the highest concentration (100 µg/mL) of strawberry dried
methanolic extract, led to a 3.06-, 2.37-, and 3.16-fold overexpression of p-AMPK/AMPK, Sirt1, and
LKB1, respectively, compared to control.
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Figure 2. Effects of stra rry dried methanolic extract on p-AMPK, AMPK, Sirt1, and L B1 expression.
HepG2 cells were treated with the indicated concentrations for 24 h. The protein signals were detected
by a Lycor C-Digit Blot Scanner and quantification was made using the software Image Studio 3.
Values are expressed as mean ± SD of three independent experiments (n = 3) and normalized to
the GADPH signal. Different superscript letters between different strawberry dried methanolic
extract concentrations for each assayed protein indicate statistical significance (p < 0.05). p-AMPK:
phosphorylated AMP-activated protein kinase; AMPK: AMP-activated protein kinase; Sirt1: sirtuin 1;
L B1: liver kinase B1; G DPH: glyceraldehyde 3-phosphat dehydrogenase.
Activation of AMPK by strawberry dried methanolic extract was accompanied by an
overexpression of the inactive form of the ACC (phosp orylated ACC) and upregulation of the
peroxisome proliferator activated receptor gamma coactivator 1-alpha (PGC-1α)—another downstream
target of AMPK—in a dose dependent manner (Figure 3). p-ACC/ACC expression was 1.58-, 1.82-,
and 2.48-fold, and PGC-1α expression 1.47-, 2.22-, and 2.47-fold higher compared to the control when
cells were treated with 10, 50, and 100 µg/mL of the strawberry dried methanolic extract, respectively.
In addition, the expression of HMG-CoA reductase (HMGCR), which catalyzes a rate limiting step
in cholesterol synthesis, was suppressed by the strawberry treatment (Figure 3). HMGCR expression
was ignificantly (p < 0.05) lower (from 0.62 to 0.52 times compared to the control) when strawberry
extract was applied at 10 µg/mL or 50–100 µg/mL, respectively. Inhibition of HMGCR and ACC
confirms the hypothesis that strawberry extracts should have positive effects in lipid metabolism in
HepG2 cells.
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Figure 3. Effects of strawberry drie methanolic extract on p-ACC, ACC, r-LDL, PGC-1α, and HMGCR
expression. H pG2 cells were treated with the indicated concentrations for 24 h. The protein
signals were det cte by a Lycor C-Digit Blo Scanner and quantification was made using the
soft re . Values are expressed as mean ± SD of three indep d nt xperiments
(n = 3) and normalized to the GADPH signal. Diff ent sup rsc ipts letters between different
st awberry dried methan li extract concentrations for each assayed protein indicate statistical
significance (p < 0.05). p-ACC: phosphorylated acetyl coenzyme A carboxylas ; ACC: acetyl
coenzyme A carb xylase; PGC-1α: peroxisome proliferator activated receptor gamma coactivator
1-alpha; HMGCR: 3-hydrox -3-methylglut ryl-CoA reductase; r-LDL: low density lipoprotein receptor;
GADPH: glyceralde yde 3-phosphate dehydrogenase.
In order to address whether strawberry extracts can influence lipid metabolism through
transcriptional regulation, the expression of LDL receptor (r-LDL) was investigated. Dried methanolic
extract at 10, 50, and 100 µg/mL led to significantly (p < 0.05) higher r-LDL expression compared to
the control by up to 2.15-, 3.29-, and 4.34-fold, respectively.
The effects of strawberry extract in the expression of all the proteins tested was also
time-dependent (Figure 4A,B). In most cases (p-AMPK, Sirt1, LKB1, p-ACC, PGC-1α), the highest
protein expression was observed after 24 h of treatment, although, the first significant effects
(p < 0.05) were observed just after 30 min. Only in the case of r-LDL and H CGR, the maximal
activation/inhibition was obtained after 48 h, respectively.
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mitochondrial functionality in treated HepG2 cells was also determined. For that purpose, the OCR 
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Increasing concentrations of strawberry dried methanolic extract had no significant (p < 0.05) 
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Figure 4. Protein ((A): p-AMPK, AMPK, Sirt1, LKB1 and (B): p-ACC, ACC, PGC-1α, HMGCR, r-LDL)
expression in HepG2 cells after treatment with strawberry dried methanolic extract for different times.
Cells were treated with 100 µg/mL of the extract. The protein signals were detected by a Lycor
C-Digit Blot Scanner. p-AMPK: phosphorylated AMP-activated protein kinase; AMPK: AMP-activated
protein kinase; Sirt1: sirtuin 1, LKB1: liver kinase B1; p-ACC: phosphorylated acetyl coenzyme A
carboxylase; ACC: acetyl coenzyme A carboxylase; PGC-1α: peroxisome proliferator activated receptor
gamma coactivator 1-alpha; HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase; r-LDL: low density
lipoprotein receptor; GADPH: glyceraldehyde 3-phosphate dehydrogenase.
Since AMPK is activated not only through its upstream kinases but also by an increase in
the AMP/ATP ratio or in response to other stimuli such as hypoxia or oxidative stress [9,35,36],
mitochondrial functionality in treated HepG2 cells was also determined. For that purpose, the OCR
was examined (Figure 5A).
Increasing concentrations of strawberry dried methanolic extract had no significant (p < 0.05)
effect on basal respiration, while they caused a diminution in the spare and the maximal respiration
compared to the control (Figure 5B).
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Figure 5. Effects of strawberry dried methanolic extract on mitochondrial respiration in HepG2
cells: XF cell Mito stress test profile (A) and spare respiratory capacity, maximal respiration and
basal respiration (B). Cells were treated with the indicated concentration for 24 h. Values are
expressed as mean ± SD of three independent experiments (n = 3). Different superscript letters
between different strawberry dried methanolic extract concentrations for each parameter in the
chart bar indicate statistical significance (p < 0.05). OCR: oxygen consumption rate; FCCP: carbonyl
cyanide-4-(trifluoromethoxy)phenylhydrazone.
To further confirm the effect of strawberry extracts on lipid metabolism through AMPK pathway
activation, HepG2 cells wer incubated with 100 µg/mL strawberry dried methanolic extract in the
resence of an AMPK inhibitor (compound C, 10 mM) or a positive control (lovastatin, 10 M). Then,
the expression of AMPK pathway related proteins was determined.
As shown in Figure 6A,B, phosphoryl tion of AMPK by strawberry dried m thanolic extract was
significantly (p < 0.05) r versed in the presence of compound C, reaching values comparable to the
untreated control.
Also, the expression of p-ACC, r-LDL, and PGC-1α was lower in the presence of the inhibitor,
supporting the role of AMPK in the activation of these proteins by strawberry extracts, at least in part.
Inhibition of HMGCR induced by strawberry extracts was also significantly (p < 0.05) reversed by
compound C treatment.
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Figure 6. Effects of strawberry dri d methanolic extract (100 µg/mL) in the expression f AMPK
pathway related proteins ((A): p-AMPK, AMPK, Sirt1, L B1 and (B): p-ACC, ACC, PG 1α, HMGCR,
r-LDL) in the presence of 10 µM Compound C (negative control) or 10 µM Lovastatin (positive
control) in HepG2 cells. Cells were treated for 24 h. Values are expressed as mean ± SD of
three independent experiments (n = 3). Different superscript letters between different assayed
conditions for each assayed protein indicate statistical significance (p < 0.05). p-AMPK: phosphorylated
AMP-activated protein kinase: AMPK: AMP-activated protein kinase; Sirt1: sirtuin 1; LKB1: liver
kinase B1; p-ACC: phosphorylated acetyl coenzyme A carboxylase; ACC: acetyl coenzyme A
carboxylase; PGC-1α: peroxisome proliferator activated receptor gamma coactivator 1-alpha; HMGCR:
3-hydroxy-3-methylglutaryl-CoA reductase; r-LDL: low density lipoprotein receptor; GADPH:
glyceraldehyde 3-phosphate dehydrogenase.
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On the contrary, and as expected, treatment with 10 µM lovastatin for 24 h led to a higher
expression of p-AMPK, with the corresponding implications for its downstream targets. It has been
demonstrated that lovastatin treatment (1–25 µM, 24 h) impairs mitochondrial function, decreases
cellular ADP/ATP ratios, and consequently activates LKB1/AMPK pathway [37]. Statins can rapidly
activate AMPK via increased Thr-172 phosphorylation in vitro and in vivo [38–40].
It was interesting that no synergistic effects were observed when the cells were simultaneously
treated with lovastatin and strawberry dried methanolic extract.
3.4. Effects of Strawberry Extract on Lipid Profile
The effects of the strawberry extract in lipid metabolism in HepG2 cells were confirmed by
determining total cholesterol, LDL-cholesterol, and triglycerides content after treatment for 24 h.
As shown in Figure 7A, strawberry dried methanolic extract significantly (p < 0.05) improved the lipid
profile in a dose dependent manner.
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Total cholesterol, LDL-cholesterol, and triglycerides levels were lower (up to 0.50-, 0.30-, and
0.40-fold) compared to control when cells were treated with the higher concentration of the extract
(100 µg/mL).
The same determinations were performed in the presence of compound C or lovastatin (Figure 7B).
In cells treated simultaneously with compound C and strawberry dried methanolic extract, the total
cholesterol, LDL-cholesterol, and triglycerides levels were, respectively, 1.27, 2.01, and 1.86 times
higher compared to cells treated exclusively with the strawberry extract (100 µg/mL). The highest
lipids content was observed in cells treated exclusively with the AMPK inhibitor, while the best results
were observed after treatment with lovastatin.
Also, the total lipid accumulation determined by O red oil staining was significantly higher
(p < 0.05) in cells treated with the inhibitor of AMPK activation and almost similar in control cells
compared to the cells treated simultaneously with compound C and strawberry extract (Figure 8).
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HepG2 cells in the presence of 10 µM Compound C (negative control) or 10 µM Lovastatin (positive
control). Cells were treated for 24 h. Stained intercellular oil droplets were eluted with isopropanol
and quantified by spectrophotometrical analysis at 510 nm. Values are expressed as ean ± SD of
three independent experiments (n = 3). Columns with different superscript letters are significantly
different (p < 0.05). CTL: untreated cells; STW: cells treated with strawberry dried methanolic extract;
C: compound C; STA: lovastatin.
4. Discussion
Beneficial effects of strawberry consumption comprise a wide range of biological
activities, from antioxidant capacity to anti-inflammatory, anti-hypertensive, and anti-proliferative
actions [11,12,19,41–43]. Epidemiological and clinical studies indicate that acute consumption of
strawberry improves postprandial glycemic response, circulating inflammatory markers, and increases
plasma antioxidant capacity. Likewise, a sustained strawberry consumption ameliorates plasma lipid
profile and decreases chronic inflammation, mainly in subjects with high risk for metabolic syndrome.
These beneficial effects have been frequently attributed to the antioxidant capacity of strawberry
bioactive compounds. However, it has been recently suggested that strawberry’s biological properties
are also related to the modulation of several molecular pathways implicated in cell proliferation,
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survival, and metabolism [43]. In this report, we showed for the first time that the effects of strawberry
extract in lipid metabolism are related to the AMPK pathway.
AMPK complex has a direct impact on glucose and lipid metabolism improving glucose uptake
and inhibiting fat accumulation through the modulation of several downstream-signaling components
like the ACC [9,10]. Thus, pharmacological activation of AMPK in the liver would be expected to
improve lipid profile and to decrease the incidence of dyslipidemia related diseases.
Our data illustrate that strawberry dried methanolic extract led not only to higher AMPK
phosphorylation but also to a higher expression of LKB1 and Sirt1 as well. LKB1 was the first upstream
kinase of AMPK phosphorylation to be described, while Sirt1 is a histone/protein deacetylase that
cross-regulates AMPK [36]. Evidence indicates that both Sirt1 and AMPK mutually affect lipid
metabolism, but their relationship in the signaling cascade appears to be uncertain [44,45].
The AMPK activation through LKB1 stimulation in HepG2 cells has been previously reported
for other natural compounds but not for strawberries. For example, Kim et al. [46] reported that
thymoquinone relieves the inflammatory response and hepatic fibrosis through the activation of the
LKB1/AMPK signaling pathway, and honokiol, a bioactive compound obtained from the stem bark of
Magnolia officinalis, protects against liver injury caused by hypoxia/reoxygenation and hepatotoxicants
via an LKB1-dependent pathway [47].
Induction of Sirt1 is also related to the expression of PGC-1α that turned out to be stimulated by
strawberry extract treatment in a dose-dependent manner. Sirt1 can directly interact and deacetylate
PGC-1α, which is closely related with enhanced PGC-1α transcriptional activation. Sirt1-mediated
regulation of PGC-1α activity may play a major role in the metabolic adaptations to energy metabolism
in different tissues [48]. In liver, Sirt1 regulates gluconeogenic activity by modulating cAMP responsive
element binding protein regulated transcription coactivator 2 and PGC-1α, which is also an important
mediator of AMPK-induced gene expression. In that sense, AMPK activation increases PGC-1α
expression at the same time as it requires PGC-1α activity to regulate the expression of several key
players in glucose and mitochondrial metabolism [49–51]. Therefore, the relation between AMPK and
PGC-1α connects the sensing of the cellular energetic status and the stimulation of transcriptional
programs that control energy expenditure [51].
Furthermore, in the present study, strawberry extract led to a higher phosphorylation of the
AMPK substrate ACC. Phosphorylation of ACC leads to its inactivation and consequently to the
acute interruption of fatty acid synthesis by blocking the conversion of acetyl CoA to malonyl CoA.
In addition, the ACC inhibition could also increase β-oxidation by promoting the activity of carnitine
palmitoyltransferase (CPT1), which is essential for the entry of long-chain fatty acids into mitochondria.
Strawberry extract also inhibited HMGCR and stimulated r-LDL, which is subjected to sensitive
feedback control that regulates intracellular and extracellular cholesterol levels. When cholesterol levels
rise within the cell, r-LDL production decrease contemporarily with the HMGCR diminution, leading
to a reduction of cholesterol input from both plasma and endogenous synthesis. On the contrary, in
cholesterol depleted cells the production of r-LDL and HMGCR are increased. The mechanism for this
dual regulation is controlled by the sterol regulatory element-binding protein (SREBP). In cholesterol
depleted cells, SREBP activates HMGCR, r-LDL, and all the other enzymes implicated in cholesterol
biosynthesis, at a transcriptional level. When LDL-derived cholesterol enters the cells, it blocks
the proteolytic release of the active fragment of SREBP from membranes, leading to a failure in the
transcription of the target genes, which in turn decreases cells cholesterol biosynthesis and prevents
cholesterol overload [52].
SREBP-mediated regulation of LDL receptors is essential for the action of statins, a class of plasma
cholesterol lowering drugs which have been found to reduce CVDs and mortality in individuals at high
risk. In the liver, statins are capable of inhibiting HMGCR and subsequently reducing the cholesterol
production. This cholesterol diminution activates SREBP-mediated regulation resulting in an increased
number of r-LDL on cell membranes and an increased amount of HMGCR. Nevertheless, cholesterol
biosynthesis is not stimulated due to the inhibitory effect of statin on the enzyme. The newly produced
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r-LDL translocate LDL from the blood into the cell, where its transformation releases cholesterol that
becomes available for metabolic purposes. The overall effect is that the amount of cholesterol in the
liver remains at a normal level while the level of LDL-cholesterol in the blood is maintained low [52].
Similar effects to those described for statins could explain the effects reported for strawberries in the
present work concerning cell cholesterol levels. In fact, our results showed that both strawberry extract
and lovastatin presented similar effects on lipid profile, cell lipid accumulation, and on the expression
of the proteins related to the AMPK pathway. Interestingly, no synergistic effects on the expression
levels of such proteins were observed when cells were treated with strawberry extract and lovastatin
simultaneously. We hypothesized that strawberry extract may interfere with the cellular uptake of
the drug and/or its metabolism. For example, it is well known that some Cytochrome P450 3A4
inducers may reduce the efficacy of lovastatin. On the contrary, the positive effects of the strawberry
extract were remarkably inhibited in the presence of the AMPK-pharmacological inhibitor compound
C, demonstrating that activation of the AMPK pathway is needed, at least in part, for the strawberry
effects on cell lipid metabolism.
Finally, strawberry extract also caused a diminution on the spare and the maximal respiratory
capacity. The spare, or reserve respiratory capacity, describes the amount of extra ATP that can be
produced by oxidative phosphorylation in case of a rapid increase in energy demand. The energy
requirement of different tissues fluctuates constantly and the ATP metabolism is correspondingly
regulated to avoid futile energy expenditure and to provide their specific needs. Concomitantly, the
mitochondrial respiration rate augments when more ATP is synthetized by mitochondria, underlying
the link between cellular ATP demand and oxidative phosphorylation regulation [53]. Therefore, a
decrease in the spare respiratory capacity and consequently a disturbance in the cellular energy state,
as described after the strawberry extract treatment in the present study, could lead to AMPK activation.
However further analyses should be performed to confirm that the AMP/ATP ratio certainly increases.
Usually, reduced mitochondrial function has been linked to the pathogenesis of numerous diseases
and their complications. However, some authors [53] have recently suggest that overstimulation of
mitochondria is a probable risk factor for insulin resistance, while moderate mitochondrial dysfunction
may actually be protective under certain conditions, suggesting the mitochondrial modulation as a
prospective therapy for metabolic diseases. In fact, it has been demonstrated that several mitochondrial
modulators ameliorate insulin sensitivity and metabolic complications [54–56]. For example, it has been
reported that metformin—which is widely used for the treatment of type 2 diabetes—directly inhibits
complex I of the electron transport chain (ETC) and thus reduces mitochondrial respiration [53,57–59].
Therefore, it can be hypothesized that strawberry extract activates AMPK not only via LKB1 but also
through alterations on the electron transport chain functionality, subsequently affecting cell energy
state. Similar results have been reported for berberine [60] and licochalcone A [61].
Activation of AMPK by strawberry methanolic extract could also be related to its antioxidant
capacity, since the AMPK pathway is implicated in the endogenous antioxidant response of the
organism through the activation of the nuclear related factor 2 and consequently of some antioxidant
responsive elements [62–64].
5. Conclusions
In summary, our results provide new insights into the molecular mechanism of the
hypocholesterolemic effects of strawberry extract. Strawberry treatment activated the energy sensing
molecule AMPK, which in turn inhibited the proteins involved in fatty acids and cholesterol synthesis.
These findings support the further employment of strawberry fruits as functional foods and a potential
hypolipidemic agent.
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